Rare dual-clone phenomenon: concurrent λ AL amyloidosis and κ-restricted Bcell lymphoproliferative disorders
Okan Çetin(Istanbul University), Vaishali Sanchorawala(Boston Medical Center), Tracy Joshi(Boston University), Andrew Staron(Boston University), Lisa M. Mendelson(Boston Medical Center)
Cited by 0
Related Papers
Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study
|Blood Cancer Journal|2021|143
Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis
|Blood Advances|2020|58
Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities
|Blood Cancer Journal|2020|43
Predictors of hematologic response and survival with stem cell transplantation in <scp>AL</scp> amyloidosis: A 25‐year longitudinal study
|American Journal of Hematology|2022|41